Class Action Lawsuit Against Vistagen Therapeutics: March 2026 Deadline for Investors to Join A class action lawsuit has been filed against Vistagen Therapeutics, providing a crucial opportunity for investors affected by securities fraud to join. Learn more about your options.

Class Action Lawsuit Against Vistagen Therapeutics: March 2026 Deadline for Investors to Join #United_States #New_York #Class_Action #Securities_Fraud #Vistagen

Shareholders of Vistagen Therapeutics Urged to Act Before Class Action Deadline Approaches As the March 16, 2026 deadline for a class action lawsuit against Vistagen Therapeutics looms, investors are reminded to seek claims for losses incurred.

Shareholders of Vistagen Therapeutics Urged to Act Before Class Action Deadline Approaches #United_States #New_York #Faruqi_&_Faruqi #Vistagen #VTGN

Investors Can Lead Class Action Lawsuit Against Vistagen Therapeutics for Securities Fraud Vistagen Therapeutics investors have the chance to participate in a class action lawsuit led by the Schall Law Firm, focusing on alleged securities fraud.

Investors Can Lead Class Action Lawsuit Against Vistagen Therapeutics for Securities Fraud #USA #Los_Angeles #Schall_Law_Firm #Securities_Fraud #Vistagen

Investors Seek Justice Against Vistagen Therapeutics, Inc. for Securities Law Breaches Vistagen Therapeutics faces a class action lawsuit for securities law violations. The DJS Law Group is encouraging affected investors to make contact.

Investors Seek Justice Against Vistagen Therapeutics, Inc. for Securities Law Breaches #United_States #Los_Angeles #DJS_Law_Group #Securities_Law_Violations #Vistagen

Class Action Lawsuit Filed Against Vistagen Therapeutics for Securities Violations Affecting Investors Investors are urged to engage with the DJS Law Group regarding a class action lawsuit against Vistagen Therapeutics related to significant securities law violations.

Class Action Lawsuit Filed Against Vistagen Therapeutics for Securities Violations Affecting Investors #USA #Los_Angeles #DJS_Law_Group #Vistagen #VTGN

Investors Alert: Vistagen Therapeutics Faces Class Action Lawsuit Over Securities Violations A class action lawsuit has been filed against Vistagen Therapeutics for alleged violations of securities laws, misleading investors about trial results.

Investors Alert: Vistagen Therapeutics Faces Class Action Lawsuit Over Securities Violations #USA #Los_Angeles #DJS_Law_Group #Vistagen #VTGN

Investors Encouraged to Join Class Action Against Vistagen Therapeutics Over Securities Fraud Allegations Vistagen Therapeutics faces a class action lawsuit for securities fraud, inviting investors to recover losses. Join the fight for accountability.

Investors Encouraged to Join Class Action Against Vistagen Therapeutics Over Securities Fraud Allegations #USA #Los_Angeles #Schall_Law_Firm #Securities_Fraud #Vistagen

Important Notice: Vistagen Investors Must Act Before March 16, 2026, Deadline Vistagen Therapeutics has been the subject of a securities class action lawsuit. Investors need to be aware of the crucial deadline of March 16, 2026, to take action.

Important Notice: Vistagen Investors Must Act Before March 16, 2026, Deadline #None #Securities_Class_Action #Faruqi_&_Faruqi #Vistagen

Pomerantz Law Firm Warns Investors of Class Action Regarding Vistagen Therapeutics Securities Fraud Investors in Vistagen Therapeutics, Inc. are alerted to a class action lawsuit over potential securities fraud claims, with key deadlines approaching.

Pomerantz Law Firm Warns Investors of Class Action Regarding Vistagen Therapeutics Securities Fraud #United_States #New_York #Securities_Fraud #Pomerantz_Law #Vistagen

Vistagen Therapeutics Investors Alerted of Deadline for Class Action Participation by Levi & Korsinsky Levi & Korsinsky informs Vistagen investors of a pressing deadline to join a class action lawsuit regarding significant financial losses over alleged fraud.

Vistagen Therapeutics Investors Alerted of Deadline for Class Action Participation by Levi & Korsinsky #United_States #New_York #Levi_&_Korsinsky #Vistagen #VTGN

Investigation Launched Over Vistagen Therapeutics' Clinical Trial Practices Amid Securities Violations Claims Levi & Korsinsky, LLP is probing potential violations by Vistagen Therapeutics regarding its clinical trial designs, impacting investor interests significantly.

Investigation Launched Over Vistagen Therapeutics' Clinical Trial Practices Amid Securities Violations Claims #USA #New_York #Levi_&_Korsinsky #Clinical_Trials #Vistagen

Investors in Vistagen Therapeutics Urged to Join Class Action Amid Securities Fraud Claims Pomerantz Law Firm informs investors of a class action lawsuit against Vistagen Therapeutics. Participants encouraged to respond by March 16, 2026.

Investors in Vistagen Therapeutics Urged to Join Class Action Amid Securities Fraud Claims #United_States #New_York #Pomerantz #Vistagen #VTGN

Vistagen Therapeutics Faces Challenges: Stock Plunges Over 80% After Clinical Trial Results Vistagen Therapeutics has experienced a dramatic stock drop of over 80% due to unpromising clinical trial results, sparking a class action lawsuit.

Vistagen Therapeutics Faces Challenges: Stock Plunges Over 80% After Clinical Trial Results #USA #New_York #Class_Action #stock_drop #Vistagen

Vistagen Therapeutics Faces Class Action Lawsuit for Alleged Securities Violations in 2026 Vistagen Therapeutics, Inc. is currently embroiled in a class action lawsuit pertaining to alleged securities law violations, attracting investor attention.

Vistagen Therapeutics Faces Class Action Lawsuit for Alleged Securities Violations in 2026 #USA #Class_Action #Los_Angeles #Securities_Law #Vistagen

Vistagen Therapeutics Faces Class Action Lawsuit Over Securities Violations Levi & Korsinsky, LLP has initiated a class action against Vistagen Therapeutics, Inc. for alleged securities law violations that impacted investors.

Vistagen Therapeutics Faces Class Action Lawsuit Over Securities Violations #United_States #California #Levi_&_Korsinsky #federal_securities #Vistagen

Vistagen Therapeutics Faces Class Action Over Securities Violations - Investor Alert Vistagen Therapeutics, Inc. is currently facing a class action lawsuit regarding securities law violations. Investors are urged to act promptly and discuss their rights.

Vistagen Therapeutics Faces Class Action Over Securities Violations - Investor Alert #United_States #DJS_Law_Group #Eastchester #Vistagen #VTGN

Investors of Vistagen Therapeutics Urged to Act Before Lawsuit Deadline in 2026 Faruqi & Faruqi, LLP notifies Vistagen Therapeutics investors of the upcoming deadline for participation in a federal securities class action lawsuit.

Investors of Vistagen Therapeutics Urged to Act Before Lawsuit Deadline in 2026 #USA #New_York #Faruqi_&_Faruqi #Investor_Alert #Vistagen

Investors Target Vistagen Therapeutics, Inc. Over Alleged Securities Violations Vistagen Therapeutics, Inc. faces a class action suit for alleged securities law violations, inviting impacted investors to seek justice.

Investors Target Vistagen Therapeutics, Inc. Over Alleged Securities Violations #USA #Los_Angeles #DJS_Law_Group #Vistagen #VTGN

Vistagen Therapeutics Faces Class Action Lawsuit: Stockholders Urged to Act Robbins LLP alerts Vistagen Therapeutics shareholders about a class action lawsuit. Urgent steps need to be taken by affected investors to participate.

Vistagen Therapeutics Faces Class Action Lawsuit: Stockholders Urged to Act #United_States #San_Diego #Class_Action #Robbins_LLP #Vistagen

Vistagen Therapeutics Investors Alerted to Class Action Over Clinical Trial Misrepresentation Levi & Korsinsky, LLP has announced a pending class action against Vistagen Therapeutics regarding allegedly misleading statements about their clinical trial operations. The upcoming lead plaintiff deadline is March 16, 2026.

Vistagen Therapeutics Investors Alerted to Class Action Over Clinical Trial Misrepresentation #USA #New_York #Class_Action #Clinical_Trials #Vistagen

Vistagen Therapeutics Investors Urged to Join Securities Fraud Class Action to Seek Compensation Investors in Vistagen Therapeutics may have a key opportunity to participate in a class action lawsuit. Details on how to join and potential compensation are provided.

Vistagen Therapeutics Investors Urged to Join Securities Fraud Class Action to Seek Compensation #USA #New_York #Class_Action #Securities_Fraud #Vistagen

Vistagen Therapeutics Faces Class Action Lawsuit Over Securities Violations Amid Investor Concerns Investors are alerted to a class action lawsuit against Vistagen Therapeutics for alleged securities law violations related to misleading trial statements.

Vistagen Therapeutics Faces Class Action Lawsuit Over Securities Violations Amid Investor Concerns #United_States #Class_Action #Securities_Law #Eastchester #Vistagen

Recent Class Action Lawsuit Filed Against Vistagen Therapeutics, Impacts on Investors Investors of Vistagen Therapeutics, Inc. are being alerted about a class action lawsuit regarding potential securities fraud, with key deadlines coming up soon.

Recent Class Action Lawsuit Filed Against Vistagen Therapeutics, Impacts on Investors #United_States #New_York #Securities_Fraud #Pomerantz_Law #Vistagen

Vistagen Therapeutics Investors Invited to Join Securities Fraud Lawsuit Led by Schall Law Firm Vistagen Therapeutics investors have a chance to lead a class action lawsuit against the company due to alleged securities fraud. Join the case today.

Vistagen Therapeutics Investors Invited to Join Securities Fraud Lawsuit Led by Schall Law Firm #United_States #Los_Angeles #Schall_Law_Firm #Securities_Fraud #Vistagen

Investors Alert: Vistagen Therapeutics Faces Class Action Lawsuit Over Trial Results Vistagen Therapeutics, Inc. faces a class action lawsuit following disappointing trial results. Shareholders are urged to register before March 16, 2026.

Investors Alert: Vistagen Therapeutics Faces Class Action Lawsuit Over Trial Results #USA #New_York #Gross_Law_Firm #Vistagen #Fasedienol

Vistagen Therapeutics Faces Class Action Lawsuit Over Alleged Securities Fraud: Join by March 16, 2026 Investors in Vistagen Therapeutics, Inc. should be aware of the ongoing class action lawsuit regarding alleged securities fraud. Deadline to join is March 16, 2026.

Vistagen Therapeutics Faces Class Action Lawsuit Over Alleged Securities Fraud: Join by March 16, 2026 #United_States #New_York #Class_Action #Levi_Korsinsky #Vistagen

Class Action Lawsuit Filed Against Vistagen Therapeutics, Inc.: Investors Urged to Act Quickly Investors of Vistagen Therapeutics, Inc. may be eligible for recovery due to a class action lawsuit regarding misleading statements about clinical trial results. Contact DJS Law Group.

Class Action Lawsuit Filed Against Vistagen Therapeutics, Inc.: Investors Urged to Act Quickly #USA #Los_Angeles #Securities_Law #Vistagen #VTGN

Investors Alert: Class Action Against Vistagen Therapeutics, Inc. Unfolds Amidst Trial Controversy Robbins LLP has filed a class action lawsuit against Vistagen Therapeutics, Inc., citing misleading statements regarding their drug trial results. Investors may be eligible to participate.

Investors Alert: Class Action Against Vistagen Therapeutics, Inc. Unfolds Amidst Trial Controversy #United_States #San_Diego #Robbins_LLP #Vistagen #VTGN

Investors of Vistagen Therapeutics Are Invited to Lead Securities Fraud Lawsuit Rosen Law Firm has announced a class action lawsuit for investors of Vistagen Therapeutics, allowing them to stand as lead plaintiffs in this securities fraud case.

Investors of Vistagen Therapeutics Are Invited to Lead Securities Fraud Lawsuit #United_States #New_York #Securities_Fraud #Rosen_Law #Vistagen

#VistaGen Therapeutics plunged nearly 80% after a key clinical trial failed, triggering intense selling and analyst downgrades, implying severe market uncertainty.

Technical indicators show the stock is deeply oversold amid extreme volatility. #VTGN